GSE129887
PAX5 promotes progression of neuroendocrine prostate cancer
Analysis of prostate adnocarcinoma cell line LNCaP cells overexpression pair box 5 (PAX5) for up to 4 days. The goals of this study are to compare PAX5 overexpression in LNCaP cell drives transcriptome profiling (RNA-seq) changes. Overall design: Examination of 6 samples of LNCaP cells including 3 vector lines and 3 overexpression PAX5 lines